Neuroscience. NAD to the rescue. [Science. 2004] - PubMed

loading

Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. [Science. 2004]
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.
Araki T, Sasaki Y, Milbrandt J. Science. 2004 Aug 13; 305(5686):1010-3.
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. [Nat Neurosci. 2001]
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.
Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, et al. Nat Neurosci. 2001 Dec; 4(12):1199-206.
A local mechanism mediates NAD-dependent protection of axon degeneration. [J Cell Biol. 2005]
A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J, Zhai Q, Chen Y, Lin E, Gu W, McBurney MW, He Z. J Cell Biol. 2005 Aug 1; 170(3):349-55. Epub 2005 Jul 25.
Review Wallerian degeneration, wld(s), and nmnat. [Annu Rev Neurosci. 2010]
Review Wallerian degeneration, wld(s), and nmnat.
Coleman MP, Freeman MR. Annu Rev Neurosci. 2010; 33:245-67.
Review Tracking in the Wlds--the hunting of the SIRT and the luring of the Draper. [Neuron. 2006]
Review Tracking in the Wlds--the hunting of the SIRT and the luring of the Draper.
Fainzilber M, Twiss JL. Neuron. 2006 Jun 15; 50(6):819-21.

Serum or target deprivation-induced neuronal death causes oxidative neuronal accumulation of Zn2+ and loss of NAD+. [Eur J Neurosci. 2010]
Serum or target deprivation-induced neuronal death causes oxidative neuronal accumulation of Zn2+ and loss of NAD+.
Sheline CT, Cai AL, Zhu J, Shi C. Eur J Neurosci. 2010 Sep; 32(6):894-904. Epub 2010 Aug 16.
SIRT1 negatively regulates the mammalian target of rapamycin. [PLoS One. 2010]
SIRT1 negatively regulates the mammalian target of rapamycin.
Ghosh HS, McBurney M, Robbins PD. PLoS One. 2010 Feb 15; 5(2):e9199. Epub 2010 Feb 15.
Review CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions. [Curr Pharm Des. 2009]
Review CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.
Chini EN. Curr Pharm Des. 2009; 15(1):57-63.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Neuroscience. NAD to the rescue.
Neuroscience. NAD to the rescue.
Science. 2004 Aug 13 ;305(5686):954-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed